DiaBench ™ Nooca Dhiigga Degdegga ah & Baaritaanka Isku-dhafka Cudurrada
1. ISTICMAALKA LA rabo
Nooca Dhiiga (ABD) Tijaabada Degdega ah (Wajiga Adag) iyo Baaritaanka Combo Infectious (Colloidal Gold) waxay ku habboon yihiin nidaamka kooxaynta dhiigga ABD A/B antigen iyo nidaamka kooxaynta dhiigga Rh D ogaanshaha antigen ee xididdada dhiigga oo dhan iyo dhiigga farta cusub ogaanshaha fayraska cagaarshow B, waraabowga spirochete, fayraska difaaca jirka bini'aadamka, iyo caabuqyada fayraska cagaarshowga C, oo kuma habboona baaritaanka dhiigga.Natiijooyinka la helay waa in la falanqeeyo iyadoo lala kaashanayo macluumaadka kale ee kiliinikada.Waxaa loogu talagalay inay isticmaalaan xirfadlayaasha caafimaadka oo keliya.
2. SHEEGIDDA Alaabada
| Qaabka No. | ABD/HCV/HBSAG/HIV/TP-AB Combo |
| Habka | Waji Adag/Dahab Dahab ah |
| Tusaalaha Nooca | xidid dhiig oo dhan/dhiigga farta cusub |
| Waqtiga Natiijada | 10-15 daqiiqo |
| Kaydinta | 2-30 ℃/36~86℉ |
| Nolosha shelf | 24 bilood |
| Shahaado | ISO13485 |
| QAYBAHA KIT UGU WEYN *Qalabka tijaabi * Tusaalaha dareeraha ah * pipette la tuuri karo * Tilmaamaha Isticmaalka | Baakad * 20 tijaabo / qalab * Calaamadaynta bacda biilka aluminiumka * duub duub
|
3.Habka tijaabada
| 1 | U akhri tilmaamaha isticmaalka oo si adag u raac tilmaamaha isticmaalka qalliinka loo baahan yahay si aad uga fogaato inay saamayso saxnaanta natiijooyinka baaritaanka. |
| 2 | Baaritaanka ka hor, xirmada iyo muunada waxaa laga soo saarayaa xaalada kaydinta waxaana la isku dheeli tiraa heerkulka qolka oo calaamadee. |
| 3 | Jeexitaanka baakadaha shandad bireed aluminium ah, ka soo saar qalabka tijaabada oo calaamadee, ka dibna si siman u dhig miiska tijaabada. |
| 4 | Muunadda la tijaabinayo (dhiigga oo dhan) waxaa lagu daray ceelasha S1 iyo S2 oo leh 2 dhibcood (qiyaastii 20ul), iyo ceelasha A,B iyo D oo leh 1 dhibcood (qiyaastii 10ul), siday u kala horreeyaan.Ka dib marka muunada lagu daro, 10-14 dhibcood oo musqul muunad ah (qiyaastii 500ul) ayaa lagu daraa ceelasha dareeraha ah waxaana la bilaabayaa wakhtiga. |
| 5 | Natiijooyinka baaritaanka waa in lagu tarjumaa 10 ~ 15 daqiiqo gudahood, haddii in ka badan 15min natiijooyinka la fasiray ay yihiin kuwo aan sax ahayn. |
| 6 | Tafsiir muuqaal ah ayaa loo isticmaali karaa tarjumaada natiijada. |
4.NATIIJADA QIIMEYNTA IYO SHARAXA
5.QAABKA Kliinikada
| Baysen natiijadaHBsAg | Natiijada tijaabada ee reagent Reference | Heerka shilalka togan:99.10% (95% CI 96.79% ~ 99.75%) Heerka shilka xun:98.37% (95% CI96.24% ~ 99.30%) Wadarta heerka shilka:98.68% (95% CI97.30% ~ 99.36%) | ||
| Wanagsan | xun | Wadarta | ||
| Wanagsan | 221 | 5 | 226 | |
| xun | 2 | 302 | 304 | |
| Wadarta | 223 | 307 | 530 | |
| Natiijada Baysen ee TP | Natiijada tijaabada ee reagent Reference | Heerka shilalka togan:95.71% (95% CI 90.97% ~ 98.02%) Heerka shilka xun:97.69% (95% CI95.67% ~ 98.78%) Wadarta heerka shilka:97.17% (95% CI95.38% ~ 98.28%) | ||
| Wanagsan | xun | Wadarta | ||
| Wanagsan | 134 | 9 | 143 | |
| xun | 6 | 381 | 387 | |
| Wadarta | 140 | 390 | 530 | |
| Baysen natiijadaHIV | Natiijada tijaabada ee reagent Reference | Heerka shilka togan:97.03% (95% CI 91.63% ~ 98.98%) Heerka shilka xun:99.77% (95% CI98.69% ~ 99.96%) Wadarta heerka shilka:99.25% (95% CI98.08% ~ 99.71%) | ||
| Wanagsan | xun | Wadarta | ||
| Wanagsan | 98 | 1 | 99 | |
| xun | 3 | 428 | 431 | |
| Wadarta | 101 | 429 | 530 | |
| Baysen natiijadaHCV | Natiijada tijaabada ee reagent Reference | Heerka shilalka togan:93.84% (95% CI 85.22% ~ 97.58%) Heerka shilka xun:99.35% (95% CI98.12% ~ 99.78%) Wadarta heerka shilka:98.68% (95% CI97.30% ~ 99.36%) | ||
| Wanagsan | xun | Wadarta | ||
| Wanagsan | 61 | 3 | 64 | |
| xun | 4 | 462 | 466 | |
| Wadarta | 65 | 465 | 530 | |
